The history of Helicobacter pylori: A reflection on the relationship between the medical community and industry

Digestive and Liver Disease

Volumn 38, Issue 10, 2006, Pages 778-780

  Ciacci, C ^a   Mazzacca, G ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Drug companies; Helicobacter pylori; Market; Medical education

Indexed keywords

BISMUTH CITRATE; HISTAMINE H2 RECEPTOR ANTAGONIST; OMEPRAZOLE; PROTON PUMP INHIBITOR; STOMACH SECRETION INHIBITOR;

ARTICLE; DRUG INDUSTRY; DRUG MARKETING; ERADICATION THERAPY; HELICOBACTER PYLORI; HISTORY; HUMAN; MEDICAL EDUCATION; MEDICAL PROFESSION; NONHUMAN; PEPTIC ULCER;

DRUG INDUSTRY; EDUCATION, MEDICAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HISTORY, 20TH CENTURY; HUMANS; INTERDISCIPLINARY COMMUNICATION; PEPTIC ULCER;

EID: 33748484046     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2006.06.013     Document Type: Article

References (24)

1. Marshall B.J. Unidentified curved bacillus on gastric epithelium in active chronic gastritis. Lancet 1 (1983) 1273-1275
2. Warren J.R. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet 1 (1983) 1273
3. Marshall B.J., and Warren J.R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1 (1984) 1311-1315
4. Parsonnet J. Clinicians-Discoverers-Marshall, Warren, and H. pylori. New Engl J Med 353 (2005) 2421-2423
5. Axon A.T.R., and Quina M. Ten-year milestones. Curr Opin Gastroenterol 10 Suppl. 1 (1994) 1-5
6. In: Marshall B.J. (Ed). Helicobacters pioneers: firsthand accounts from the scientists who discovered helicobacters 1892-1982 (2002), Blackwell, Victoria, Australia
7. Coughlan J.G., Gilligan D., Humphries H., McKenna D., Dooley C., Sweeney E., et al. Campylobacter pylori and recurrence of duodenal ulcer disease-a 12 month follow up study. Lancet 2 (1987) 1109-1111
8. Homick R.B. Peptic ulcer disease. A bacterial infection?. N Engl J Med 316 (1987) 1598-1600
9. Tytgat G.N. Colloidal bismuth subcitrate in peptic ulcer-a review. Digestion 37 Suppl. 2 (1987) 31-41
10. Marshall B.J., Armstrong J.A., Francis G.J., Nokes N.T., and Wee S.H. Antibacterial action of bismuth in relation to Campylobacter pyloridis colonization and gastritis. Digestion 37 Suppl. 2 (1987) 16-30
11. Marshall B.J., Goodwin C.S., Warren J.R., Murray R., Blincow E.D., Blackbourn S.J., et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 2 (1988) 1437-1442
12. Bayerdorffer E., and Ottenjann R. The role of antibiotics in Campylobacter pylori associated peptic ulcer disease. Scand J Gastroenterol 142 Suppl. (1988) 93-100
13. Borsch G. Campylobacter pylori and therapy with bismuth salts. Med Monatsschr Pharm 1 (1988) 301-307
14. Clissold S.P., and Campoli-Richards D.M. Omeprazole. A preliminary report of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome. Drugs 32 (1986) 15-47
15. Peptic ulcer medication usage, United States, 1989. Stat Bull Metrop Insur Co 1990;71:10-7.
16. Panton R. Prescribing in the West Midlands: West Midlands Region Annual Prescribing Report 1996-1997. Keele University; 1997.
17. The International Symposium on OMEPRAZOLE, Programme and Abstracts. Monte-Carlo, Monaco. 11-12 November 1988. ASTRA.
18. Martin J.B., and Kasper D.L. In whose best interest? Breaching the academic-industrial wall. N Engl J Med 343 (2000) 1646-1649
19. Tenery R.M. Interactions between physicians and the health care technology industry. J Am Med Assoc 283 (2000) 391-393
20. Relman A.S. Separating continuing medical education from pharmaceutical marketing. J Am Med Assoc 285 (2001) 2009-2012
21. Warner T.D., and Gluck J.P. What do we really know about conflict of interest in biomedical research?. Psychopharmacology 171 (2003) 36-46
22. Blumenthal D. Doctors and drug companies. N Engl J Med 351 (2004) 1885-1890
23. Lichtenberg F.R. Pharmaceutical knowledge-capital accumulation and longevity. In: Corrado C., Haltiwanger J., and Sichel D. (Eds). Measuring capital in new economy (2005), University of Chicago Press, Chicago
24. Studdert D.M., Mello M.M., and Brennan T.A. Financial conflicts of interest in physicians' relationships with the pharmaceutical industry-self-regulation in the shadow of Federal prosecution. N Engl J Med 351 (2004) 1891-1900